AHSCT

常見(jiàn)例句

The preliminary result suggested that AHSCT could prolong the disease - free survival for AL, HD and ALC.
初步結(jié)果提示AHSCT能延長(zhǎng)AL、HD和ALC患者的無(wú)病存活期。
Autologous hematopoietic stem cell transplantation(AHSCT)
自體造血干細(xì)胞移植
5 AL and 1 HD were still in continuous complete remission to 450, 313, 276, 112, 81 and 171 days after AHSCT respectively, intracrania1 metastases relapsed in ALC after 1l5 days of complete remission.
5例AL和1例HD已分別持續(xù)完全緩解450天、313天、276天、112天、81天和171天； 1例則ALC患者在移植后完全緩解115天后出現(xiàn)顱內(nèi)復(fù)發(fā)。